Elizabeth C Wescott

6PUBLICATIONS
46CO-AUTHORS
Predictive and prognostic markersInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 22, 2026
Peripheral blood transcriptional profiling predicts tumor subtype and neoadjuvant chemoimmunotherapy outcomes in human breast cancer.

|Dec 10, 2025
Monitoring systemic immune responses to checkpoint inhibition in breast cancer reveals host responses and mechanisms of resistance.

Ann Hanna, Xiaopeng Sun, Quanhu Sheng

|Apr 30, 2024
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer.

Elizabeth C Wescott, Xiaopeng Sun, Paula Gonzalez-Ericsson

|Oct 04, 2023
NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer.

Brandie C Taylor, Xiaopeng Sun, Paula I Gonzalez-Ericsson

|Dec 01, 2020
A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor-Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention.

Spencer C Wei, Wouter C Meijers, Margaret L Axelrod

|May 16, 2020
Therapeutic vaccination with IDLV-SIV-Gag results in durable viremia control in chronically SHIV-infected macaques.

Maria Blasi, Elizabeth C Wescott, Erich J Baker

Pageof 1

Frequent Collaborators

5 joint publications

Justin M Balko

4 joint publications

Xiaopeng Sun

3 joint publications

Ann Hanna

3 joint publications

Brandie C Taylor